Skip to content
DataLookout
Menu

NCT07909499

BD Onclarity HPV Assay on the BD COR Instrument: Self-collected Vaginal Swabs Validation

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Clinical Sensitivity of Self-Collected Vaginal Swabs for Detection of High-Risk HPV
Timeframe: At specimen collection and completion of laboratory testing (up to 30 days)
Overall Agreement Between Self-Collected Vaginal Swabs and Reference Laboratory HPV Results
Timeframe: At specimen collection and completion of laboratory testing (up to 30 days)
Clinical Specificity of Self-Collected Vaginal Swabs for Detection of High-Risk HPV
Timeframe: At specimen collection and completion of laboratory testing (up to 30 days)

Secondary (2)

Type-Specific HPV Genotype Agreement
Rate of Invalid or Unsatisfactory Results

Arms and interventions

BD Onclarity Self-Collection ValidationExperimental

Participants will provide two self-collected vaginal specimens during a single study encounter: one specimen using the currently validated in-office self-collection method and one specimen using the BD Onclarity At-Home Self-Collection Kit. Both specimens will be tested using the BD Onclarity HPV Assay on the BD COR System. Results from the paired specimens will be compared to support laboratory validation of at-home self-collected HPV testing prior to clinical implementation at IU Health.

Devices: BD Cor OnClarity Self-Collection

Diagnostic tests: BD Onclarity HPV Assay

Sites

1 site in 1 country

  • Indiana University, Department of PathologyIndianapolis, Indiana, United States